Array BioPharma
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is currently a subsidiary of Pfizer after being acquired for $11 billion in 2019.
Basic Information
- Category: Pharmaceuticals & Healthcare
- Founded: 1998
- Headquarters: Boulder, CO
- Website: https://www.arraybiopharma.com
Documented Facts
- Founded: 1998 (No linked source recorded for this statement.)
- Headquarters: Boulder, CO (No linked source recorded for this statement.)
- Category: Pharmaceuticals & Healthcare (No linked source recorded for this statement.)
Products and Services
- Array BioPharma Products: American biopharmaceutical company from Pfizer.
Evidence and Sources
- Official Website (Primary Source)
- Array BioPharma — Wikipedia (reference)
Citation Guidance
Explore Pharmaceuticals & Healthcare profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Array BioPharma.
- Canonical profile: https://brandsource.ai/brands/array-biopharma
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/array-biopharma/json-ld
- Citation profile API: https://brandsource.ai/api/brands/array-biopharma/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (79/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-01
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is currently a subsidiary of Pfizer after being acquired for $11 billion in 2019.
Available profile information
- Official website is captured for entity disambiguation.
- 2 supporting sources linked.
- 3 structured facts available for extraction.
- 1 product or service signal captured.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.